Imatinib and beyond - the new CML study IV - A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia

被引：21

作者：

Berger, U ^{[1
]}

Engelich, G ^{[1
]}

Reiter, A ^{[1
]}

Hochhaus, A ^{[1
]}

Hehlmann, R ^{[1
]}

机构：

[1] Heidelberg Univ, Klinikum Mannheim, Med Univ Klin 3, D-68305 Mannheim, Germany

来源：

ANNALS OF HEMATOLOGY | 2004年 / 83卷 / 04期

关键词：

chronic myeloid leukemia; clinical trial; imatinib; interferon alpha; stem cell transplantation;

D O I：

10.1007/s00277-003-0807-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：258 / 264

页数：7

共 42 条

[1]

Baccarani M, 1999, J CLIN ONCOL, V17, P1858

[2] A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia [J].

Baccarani, M ;

Rosti, G ;

de Vivo, A ;

Bonifazi, F ;

Russo, D ;

Martinelli, G ;

Testoni, N ;

Amabile, M ;

Fiacchini, M ;

Montefusco, E ;

Saglio, G ;

Tura, S .

BLOOD, 2002, 99 (05) :1527-1535

[3] Chronic myeloid leukemia in the elderly:: long-term results from randomized trials with interferon α [J].

Berger, U ;

Engelich, G ;

Maywald, O ;

Pfirrmann, M ;

Hochhaus, A ;

Reiter, A ;

Metzgeroth, G ;

Gnad, U ;

Hasford, J ;

Heinze, B ;

Heimpel, H ;

Hossfeld, DK ;

Kolb, HJ ;

Löffler, H ;

Pralle, H ;

Queisser, W ;

Hehlmann, R .

LEUKEMIA, 2003, 17 (09) :1820-1826

[4] Chronic myeloid leukemia and interferon-α:: a study of complete cytogenetic responders [J].

Bonifazi, F ;

de Vivo, A ;

Rosti, G ;

Guilhot, F ;

Guilhot, J ;

Trabacchi, E ;

Hehlmann, R ;

Hochhaus, A ;

Shepherd, PCA ;

Steegmann, JL ;

Kluin-Nelemans, HC ;

Thaler, J ;

Simonsson, B ;

Louwagie, A ;

Reiffers, J ;

Mahon, FX ;

Montefusco, E ;

Alimena, G ;

Hasford, J ;

Richards, S ;

Saglio, G ;

Testoni, N ;

Martinelli, G ;

Tura, S ;

Baccarani, M .

BLOOD, 2001, 98 (10) :3074-3081

[5] Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia [J].

Clift, RA ;

Radich, J ;

Appelbaum, FR ;

Martin, P ;

Flowers, MED ;

Deeg, HJ ;

Storb, R ;

Thomas, ED .

BLOOD, 1999, 94 (11) :3960-3962

[6]

Delannoy A, 1997, J NATL CANCER I, V89, P1616

[7] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].

Druker, BJ ;

Tamura, S ;

Buchdunger, E ;

Ohno, S ;

Segal, GM ;

Fanning, S ;

Zimmermann, J ;

Lydon, NB .

NATURE MEDICINE, 1996, 2 (05) :561-566

[8] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[9]

Gale RP, 1998, BLOOD, V91, P1810

[10]

GOLDMAN JM, 1993, BLOOD, V82, P2235

← 1 2 3 4 5 →